---
figid: PMC10537735__pharmaceutics-15-02248-g001
pmcid: PMC10537735
image_filename: pharmaceutics-15-02248-g001.jpg
figure_link: /pmc/articles/PMC10537735/figure/pharmaceutics-15-02248-f001/
number: Figure 1
figure_title: ''
caption: 'Three-dimensional chemical structures of (A) curcumin (Cu; PubChem compound
  identifier (CID): 969516); (B) demethoxycurcumin (De; PubChem CID: 5469424); (C)
  bisdemethoxycurcumin (Bis; PubChem CID: 5315472); and (D) IκBα/p50/p65 protein complex
  (Protein Data Bank (PDB) ID: 1IKN, consisting of p65 (chain A), p50D (chain C),
  and IκBα (chain D) subunits). The structures of the curcuminoid substances (Cu,
  De, and Bis) and the protein complex were retrieved from the PubChem and PDB databases,
  respectively.'
article_title: Modified Curcuminoid-Rich Extract Liposomal CRE-SDInhibits Osteoclastogenesis
  via the Canonical NF-κB Signaling Pathway.
citation: Sompot Jantarawong, et al. Pharmaceutics. 2023 Sep;15(9):2248.
year: '2023'

doi: 10.3390/pharmaceutics15092248
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- curcuminoid
- liposomal CRE-SD
- osteoclastogenesis
- RANKL-stimulated RAW 264.7 macrophage
- canonical NF-κB signaling pathway

---
